AstraZeneca PLC (LON:AZN)
12,900
+66 (0.51%)
Nov 7, 2025, 4:50 PM BST
AstraZeneca Employees
AstraZeneca had 94,300 employees as of December 31, 2024. The number of employees increased by 4,400 or 4.89% compared to the previous year.
Employees
94,300
Change (1Y)
4,400
Growth (1Y)
4.89%
Revenue / Employee
458.57K GBP
Profits / Employee
74.15K GBP
Market Cap
200.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94,300 | 4,400 | 4.89% |
| Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
| Dec 31, 2022 | 83,500 | 400 | 0.48% |
| Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
| Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
AstraZeneca News
- 5 hours ago - AstraZeneca PLC 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 1 day ago - AstraZeneca (AZN) Warns UK on Drug Spending Risks - GuruFocus
- 1 day ago - AstraZeneca (AZN) Reports Positive Phase III Trial Results for Fasenra - GuruFocus
- 1 day ago - Statistically significant NATRON Phase III trial results for hypereosinophilic syndrome show FASENRA delayed time to first flare or worsening of disease - Business Wire
- 1 day ago - Company News for Nov 7, 2025 - Nasdaq
- 2 days ago - Why AstraZeneca Stock Topped the Market on Thursday - The Motley Fool
- 2 days ago - AstraZeneca PLC (AZN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - AstraZeneca: Solid Results, But Risks Emerge (Rating Downgrade) - Seeking Alpha